Showing results (1771-1780 of 1,932) with videos related to

Sort By:
Pageof 194
RMD Open|July 25, 2024
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational studySara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, et al.
RMD Open|July 25, 2024
Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?Lea Stamm, Alexandru Garaiman, Mike Oliver Becker, et al.
RMD Open|August 29, 2024
Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritisMartin Rudwaleit, Helena Marzo-Ortega, Victoria Navarro-Compán, et al.
RMD Open|August 29, 2024
Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's diseaseRenaud Felten, Anne-Perrine Foray, Pascal Schneider, et al.
RMD Open|August 14, 2024
More severe parotid gland histopathology in paediatric-onset than in adult-onset Sjögren's diseaseGeertje Elizabeth Legger, Uzma Nakshbandi, Martha S van Ginkel, et al.
RMD Open|August 20, 2024
Arrhythmia in patients with systemic sclerosis: incidence, risk factors and impact on mortality in a Swedish register-based studyMajd Bairkdar, Zihan Dong, Pontus Andell, et al.
RMD Open|September 5, 2024
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trialsKaren Holten, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
RMD Open|June 28, 2024
Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA studyPeter C Taylor, Georg Schett, Tom Wj Huizinga, et al.
RMD Open|June 17, 2024
Synthesis of guidance available for assessing methodological quality and grading of evidence from qualitative research to inform clinical recommendations: a systematic literature reviewMandeep Sekhon, Annette de Thurah, George E Fragoulis, et al.
RMD Open|June 17, 2024
Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance databaseRyoko Sakai, Eiichi Tanaka, Eisuke Inoue, et al.
Pageof 194